Placebo (ID)

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

DengueInfluenza

Phase 1

Higher Dose Intradermal H5 Vaccine

CompletedNCT00439335

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2007-03-31End: 2008-02-29Updated: 2013-04-09

Tetravalent Chimeric Dengue Vaccine Trial

CompletedNCT01110551

National Institute of Allergy and Infectious Diseases (NIAID)Dengue

Start: 2010-05-31End: 2012-12-31Updated: 2013-02-04

Related Papers

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

The Journal of Infectious Diseases2015-03-1986 citations

Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.

2012-08-1317 citations